HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Another study investigated the association between HSD17B13 and liver disease and showed that the HSD17B13 rs72613567 TA variant reduced the risks of alcohol-, NAFLD-, and hepatitis C-related cirrhosis and alcohol-related HCC [14].